Parkinson's Disease Trial, Recruiting NCT06580977 Sponsor: Heidelberg University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06580977
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Parkinson's disease
  • People whose Parkinson's disease is at stage 3 or below on a standard disease progression scale called the Hoehn & Yahr scale (confirm with trial site)
  • People between 50 and 80 years of age
  • People who have not previously done the specific memory tests used in this trial
  • People who are able to stand and walk at least 10 metres on their own without assistance

Who may not be able to join:

  • People who have a form of Parkinsonism that is considered "atypical" (a different condition that can look like Parkinson's disease)
  • People who have a significant level of memory or thinking difficulties, based on a standard cognitive test called the Montreal Cognitive Assessment, with a score below 21
  • People who have a deep brain stimulator or brain pacemaker implanted
  • People who have a diagnosed psychiatric illness
  • People who have other significant neurological, internal health, or bone and joint conditions (besides Parkinson's disease) that could interfere with exercise-based activities in the trial
  • People who are already doing more than the recommended amount of cardiovascular exercise for older adults — meaning 150 minutes or more per week of moderate-intensity exercise, or 75 minutes or more per week of vigorous-intensity exercise

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Simon Steib, Prof. Dr., Heidelberg University

Phone: +49 6221/544643

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Heidelberg University
Registry
ClinicalTrials.gov
Start date
27 February 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Non-declarative, procedural memory (motor sequence learning) global learning score - Visuomotor Serial Targeting Task (VSTT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov